Search results
Added:
8 months ago
Source:
Radcliffe Cardiology
The decision to switch frail, elderly patients with atrial fibrillation (AF) from a stable vitamin K antagonist (VKA) regimen to a direct-acting oral anticoagulant (DOAC) remains a subject of clinical debate. A new substudy from the COMBINE-AF dataset provides clarity, suggesting that while the switch reduces severe outcomes like stroke and death, it does not lower the risk of major bleeding and…
View more
Author(s):
Renato D Lopes
Added:
1 year ago
ESC Congress 24 — AF screening with a wearable ECG device increases diagnosis by over 50% but did not significantly reduce hospitalisation rates for stroke.We are joined onsite at ESC Congress 2024 by Dr Renato Lopes (Duke University Medical Center, NC) to discuss the findings from the GUARD-AF Trial (NCT04126486, Bristol-Myers Squibb), which was designed to determine if screening for undiagnosed…
View more
Matthew Dixon
Author
Ken Okumura
Research Area(s) / Expertise:
Author
Michael Fu
Job title: Professor, Principal Investigator, Senior Consultant Physician/Cardiologist
Author
Marjorie L King
Job title: Director of Cardiac Services
Author
Venice Arrhythmias 26
Start date:
Oct 31, 2026
End date:
Oct 29, 2026
Event
John McNeill
Job title: Professor and head of School of Public Health and Preventive Medicine
Author
Robert H Fagard
Job title: Chief of the Hypertension and Cardiovascular Rehabilitation Unit at the Department of Cardiovascular Diseases, Faculty of Medicine
Author
Prakash Deedwania
Job title: Professor of Medicine
Author